|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 11.61 USD | +1.62% |
|
+3.85% | -42.98% |
| 09-29 | Keros Therapeutics Expects $20 Million Milestone Payment From Takeda | MT |
| 09-29 | Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda | CI |
Stock exchange
Quotes 5-day view: Keros Therapeutics, Inc.
Delayed Quote Nasdaq
| 22/10/2026 | 23/10/2026 | 26/10/2026 | 27/10/2026 | 28/10/2026 | |
|---|---|---|---|---|---|
| Last | US$11.35 | US$11.28 | US$11.33 | US$11.43 | US$11.61 |
| Volume | 115,512 | 120,901 | 112,410 | 148,511 | 182,762 |
| Change | +1.52% | -0.62% | +0.44% | +0.84% | +1.62% |
| Opening | US$11.15 | US$11.28 | US$11.30 | US$11.37 | US$11.34 |
| High | US$11.44 | US$11.34 | US$11.51 | US$11.63 | US$11.79 |
| Low | US$11.15 | US$10.92 | US$11.20 | US$11.19 | US$11.20 |
Performance
| 1 day | +1.62% | ||
| 1 week | +3.85% | ||
| Current month | +1.84% | ||
| 1 month | +2.93% | ||
| 3 months | +15.29% | ||
| 6 months | +2.11% | ||
| Current year | -42.98% | ||
| 1 year | -23.52% | ||
| 3 years | -58.03% | ||
| 5 years | -72.50% |
Volumes
marketsDaily volume
183,223
Estimated daily volume
183,223
Avg. Volume 20 sessions
164,595
Daily volume ratio
1.11
Avg. Volume 20 sessions USD
1,910,947.95
Record volume 1
14,645,678
Record volume 2
13,601,225
Record volume 3
5,812,484
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
226,525,622
Net sales (USD)
244,061,000
Number of employees
92
Sales / Employee (USD)
2,652,837
Free-Float
46.49%
Free-Float capitalization (USD)
217,546,852
Average Daily Capital Traded
0.84%
Indicators
Moving average 5 days
11.31
Moving average 20 days
11.29
Moving average 50 days
11.23
Moving average 100 days
10.92
Price spread / (MMA5)
-2.56%
Price spread / (MMA20)
-2.76%
Price spread / (MMA50)
-3.31%
Price spread / (MMA100)
-5.91%
STIM
RSI 9 days
51.75
RSI 14 days
51.2
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.62% | +3.85% | -23.52% | -58.03% | 227M | |
| +0.65% | -3.36% | +36.98% | +60.50% | 63.48B | |
| +1.76% | +1.27% | +11.82% | +81.21% | 54.55B | |
| -0.94% | +0.99% | +10.45% | +100.19% | 53.59B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 44.75B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 41.62B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 39.91B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +92.73% | 26.7B | |
| +3.72% | -6.23% | +26.01% | -2.99% | 23.36B | |
| Average | +4.26% | -0.35% | +45.02% | +140.74% | 38.07B | |
| Weighted average by Cap. | +3.23% | -0.29% | +48.14% | +161.34% |
Historical Quotes: Keros Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
ccc7e14628e698edf505580.9gAACz5ZqxSR9ys-IYzgBSZSaG6hbuhbfRplyZVbEiQ.wkpweHYO-FCgmhgLZ7nXbkwgGTuMGb4WKCgpo80DXEDBcDRqU2z_TKKvHw
| Date | Price | Volume | Total |
|---|---|---|---|
| 20:00:00 | 11.61 | 22,740 | 126,546 |
| 19:59:59 | 11.63 | 100 | 103,806 |
| 19:59:58 | 11.62 | 1,754 | 103,706 |
| 19:59:54 | 11.62 | 200 | 101,952 |
| 19:59:49 | 11.62 | 100 | 101,752 |
| 19:59:48 | 11.61 | 100 | 101,652 |
| 19:59:48 | 11.61 | 100 | 101,552 |
| 19:59:48 | 11.61 | 200 | 101,452 |
| 19:59:48 | 11.61 | 146 | 101,252 |
| 19:59:48 | 11.61 | 200 | 101,106 |
Price Extremes
| 1 week | 10.92 |  | 11.79 |
| 1 month | 10.63 | | 12.26 |
| Current year | 9.69 | | 20.34 |
| 1 year | 9.69 | | 22.55 |
| 3 years | 9.12 | | 73 |
| 5 years | 9.12 | | 73 |
| 10 years | 9.12 | | 88.8 |
Monthly variations
Annual variations
| 2026 | -42.98% | ||
| 2025 | +28.62% | ||
| 2024 | -60.19% | ||
| 2023 | -17.20% | ||
| 2022 | -17.93% | ||
| 2021 | -17.05% | ||
| 2020 | +251.29% |
- Stock Market
- Stocks
- KROS Stock
- Quotes Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
